-
@ 1d14ecdd:952ab546
2025-03-12 23:11:55
https://archive.org/details/the-fauci-covid-19-dossier_202109#:~:text=On%20April%2019%2C%202002%20%E2%80%94,%E2%80%9Can%20infectious%2C%20replication%20defective%2C%20coronavirus.%E2%80%9D
On April 19, 2002 – the Spring before the first SARS outbreak in Asia – Christopher M. Curtis, Boyd Yount, and Ralph
Baric filed an application for U.S. Patent 7,279,372 for a method of producing recombinant coronavirus. In the first
public record of the claims, they sought to patent a means of producing, “an infectious, replication defective,
coronavirus.” This work was supported by the NIH grant referenced above and GM63228. In short, the U.S. Department
of Health and Human Services was involved in the funding of amplifying the infectious nature of coronavirus between
1999 and 2002 before SARS was ever detected in humans.